Peer Review History
| Original SubmissionJuly 4, 2019 |
|---|
|
PONE-D-19-18894 A national survey of videolaryngoscopy in Hungary PLOS ONE Dear Dr. Nagy, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Sep 21 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Mohamed R El-Tahan, MD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include copies of the survey questions or questionnaires used in the study, in both the original language as well as English, as Supporting Information, or include a citation if they have been published previously. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 4. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was suitably informed and (2) what type you obtained (for instance, written or through a question on the questionnaire). If the need for explicit consent was waived by the ethics committee, please include this information. 5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Paper by Nagy and Rendeki covers an interesting topic in era of large debate and discussion in era of videolaryngoscopes. English is fluent, methodology correct, though some more data would have been interesting for evaluation. Discussion is adequate, and some more (minor) issues could be addressed (see below). References are adequate and updated; consider to add some more as per comments below. Appendix not available for consultation. Page 4, line 9, consider adding a more comprehensive review as reference: Frova G, SORBELLO M. Algorithms for difficult airway management: a review. Minerva Anestesiologica 2009, 75(4): 201-209. Page 5 line 2: please state precisely date of initiation of survey. Page 5, lines 5-7: the sentence “The study presumed that the connection between the patient and the device used for airway management is the anesthesiologist.” is clear, but I would reformulate; I would also add a note whether the VLS were used by non-anesthesiologists. In fact, as from abstract, only 805 of responders were specialists and only 68% were anesthesiologists. Please also address in text if in your national educational program, anesthesia and intensive care are different specialties or different training programs. Page 5: The authors list both videolaryngoscopes and optical/digital stylets (Bonfils, Levithan, Shikani), modified classic laryngoscopes (Upsherscope, Bullard, WuScope) and other devices (C-trach). I would address this information in title and rest of text, probably changing into “videolaryngoscopes and alternative intubation devices”. Also, presentation of data (either tables/figures) could take account of this classification, for the sake of precision. Page 9 line 5: any data about failure rate for VLS? Or some information about decision to use fiberoptic scope rather than VLS? Page 10, line 13: provide reference for UK NAP4. Some points I would furtherly address in discussion: - Which role for bougies as adjunct in airway management? Any data? - I would underline also with references that VLS might fail (Aziz MF, Brambrink AM, Healy DW, Willett AW, Shanks A, Tremper T, Jameson L, Ragheb J, Biggs DA, Paganelli WC, Rao J, Epps JL, Colquhoun DA, Bakke P, Kheterpal S. Success of Intubation Rescue Techniques after Failed Direct Laryngoscopy in Adults: A Retrospective Comparative Analysis from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2016; 125: 656-66.), that they cannot be a definitive solution, as they do not provide oxygenation in apneic patient (Sgalambro F, Sorbello M. Videolaryngoscopy and the search for the Holy Grail. Br J Anaesth. 2017 Mar 1;118(3):471-472.) and finally that strategy needs to be considered a first important point, independently on availability of whichever device (Sorbello M, Afshari A, De Hert S. Device or target? A paradigm shift in airway management with implications for guidelines, clinical practice and teaching. European Journal of Anaesthesiology, 2018 Nov; 35 (11): 811-814.) - Some further comments about importance of training, also considering that success rate with VLS is related to experience in their daily use. Reviewer #2: Dear Authors, I read with interest your manuscript. It is an interesting study, nevertheless I have some concerns . General comments As mentioned by the authors, this is the first study on VLs in the so-called “Eastern-European” countries (I would eliminate this denomination, leaving just Hungary, not introducing a further biasing term, we don’t know how is the situation in other neighboring countries), There are several confusing points that should be clarified: - The “units” that the authors mention – surgery, traumatology, intensive care, ENT, …these are probably the subspecialities where the responding anesthesiologists are working, inside the OR or outside it (ICU), isn’t it? That needs more precision in the text, for correct understanding by anesthesiologists who are not necessarily familiar with the Hungarian system. - There is a very huge availability of VLs on the market generally, and in Hungary too, depending of course on multiple factors. I would skip the repetition several times of very rarely or never used devices, and leave just the most used ones. - Videolaryngoscopy means better visualization, not necessarily better intubation – in what consists exactly the training for VL use that the authors mention several times? Knowing that VLs exist and how they work, or using them in mannequins and thereafter in clinical settings? - If I understand correctly, the exact purpose of the study was to evaluate the proportion of anesthesiologist using VLs, the most used VLs, and the time needed to have them ready. That should be stated more clearly. - Moreover, what this study will teach to other anesthesiologists, either from Hungary or from abroad? What is the clear message emanating from this study. Specific comments Abstract Results This phrase is not very clear, please reformulate it. It’s not clear that they were either anesthesiologists participating in the study, or surgeons or trauma specialists? Were there 324 or 210 responders actually? In the abstract is not clear (even if in the final text of the manuscript is OK) “”…hundred and ten (65%) responders had access to various videolaryngoscopes and were mainly from surgery, intensive care and traumatology units. No responders reported the availability of eight videolaryngoscopes out of the eighteen listed devices, and 32% of the responders had never used any videolaryngoscope in clinical settings.” Manuscript Results In the table, including the “professional activities” how people who are not doing clinical anesthesia (education, administration, other) could use VLs? In the same table, it would be interesting to define the activities of the several types of hospitals cited, in order to have an idea which type of surgery/ in which cases the VLs are used – obviously, difficult intubation occurs more frequently in the delivery room for CS, in facial trauma patients, in ENT surgery, …. Availability of VLs If there were several brands of VLs that were never reported to have been used, they should not be included in the study. Patterns of use “One hundred and four responders (32%) said that they had never ever used any videolaryngoscope in clinical settings. A similar number of colleagues (n=118, 36%) stated that they never use VL. Only 39% (n=126) confirmed that they used VL at least once per month.” – I don’t understand this phrase –“never used in clinical settings vs they never use VL” – what’s the difference? Discussion The discussion is quite clear, and its understanding is good, nevertheless, I would mention the total number of anesthesiologists in the materials and methods section, as well as the proportion of responders in the results section, even if it’s repeated in the discussion again. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Massimiliano Sorbello Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A national survey of videolaryngoscopes and alternative intubation devices in Hungary PONE-D-19-18894R1 Dear Dr. Nagy, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Mohamed R. El-Tahan, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am happy with all changes, thank to the Authors for their efforts. Please just check a final round for typos and formats Reviewer #2: I would like to thank the Authors of this manuscript for their answers and corrections. They have done a great job! ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Laszlo L. SZEGEDI, M.D., PhD, Brussels, Belgium |
| Formally Accepted |
|
PONE-D-19-18894R1 A national survey of videolaryngoscopes and alternative intubation devices in Hungary Dear Dr. Nagy: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Mohamed R. El-Tahan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .